HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-ASA-glutamate protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid.

AbstractBACKGROUND AND AIMS:
A new amino acid derivative of 5-aminosalicylic acid, 5-ASA-glutamate, releases 5-aminosalicylic acid independently of the action of bacterial azoreductases or adapt intestinal pH. In this study, 5-ASA-glutamate was compared with sulphasalazine with respect to: 1) therapeutic action, 2) effects on the synthesis of eicosanoids, 3) regional release of 5-aminosalicylic acid in the intestine.
METHODS:
Colitis was induced in 29 rats by intracolonic administration of trinitrobenzensulfonic acid. Nine animals received an equal amount of saline. Three days after induction of colitis, animals were randomly assigned to equimolecular doses of 5-aminosalicylic acid as sulphasalazine (1040 mg/kg bw day) or 5-ASA-glutamate (850 mg/kg bw day) or arabic gum in water, given intragastrically. Arabic gum was also administered to animals that had received a saline enema (control group). The guts of 3 rats from the 5-ASA-glutamate group and 3 from the sulphasalazine group were used to assess regional release of 5-ASA, while in all the others, after 21 days of treatment, macroscopic and histologic lesions were assessed and eicosanoids and leukotriene determinations were performed.
RESULTS:
The 5-ASA-glutamate group had macroscopic (2.20 +/- 0.58) and histologic (2.80 +/- 1.24) significantly lower scores than the trinitrobenzensulfonic acid group (3.40 +/- 0.22 and 6.50 +/- 1.2 respectively). 5-ASA-glutamate group had reduced PGE2 (-31%) and TXB2 (-25%) more effectively than the sulphasalazine group. LTB4 release was not affected by 5-ASA-glutamate treatment, while sulphasalazine produced a non significant, but quite consistent, reduction in LTB4 release (-37%). The release of 5-ASA after sulphasalazine was higher in the small intestine, lower in the colon compared to that following 5-ASA-glutamate administration.
CONCLUSIONS:
5ASA-glutamate was effective in reducing the macroscopic and histologic score in the trinitrobenzensulfonic acid induced colitis. It also had some effect in reducing eicosanoid synthesis and could be a promising drug for the treatment of inflammatory bowel disease.
AuthorsC Clerici, G Gentili, R Pellicciari, P Gresele, A M Mezzasoma, M Giansanti, M Clementi, G Bartoli, S Balò, R Modesto, A G Aburbeh, O Morelli, A Morelli
JournalItalian journal of gastroenterology and hepatology (Ital J Gastroenterol Hepatol) Vol. 30 Issue 4 Pg. 385-90 (Aug 1998) ISSN: 1125-8055 [Print] Italy
PMID9789134 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • 5-ASA-glutamate
  • Anti-Inflammatory Agents, Non-Steroidal
  • Eicosanoids
  • Glutamates
  • Leukotrienes
  • Prostaglandins
  • Sulfasalazine
  • Trinitrobenzenesulfonic Acid
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology, therapeutic use)
  • Chromatography, High Pressure Liquid
  • Colitis (chemically induced, drug therapy, metabolism)
  • Colon (drug effects, pathology)
  • Disease Models, Animal
  • Eicosanoids (biosynthesis)
  • Glutamates (pharmacokinetics, therapeutic use)
  • Leukotrienes (biosynthesis)
  • Prostaglandins (biosynthesis)
  • Radioimmunoassay
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Statistics, Nonparametric
  • Sulfasalazine (pharmacology, therapeutic use)
  • Trinitrobenzenesulfonic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: